Moderna President Stephen Hoge executed planned stock transactions
Moderna President Stephen Hoge executed stock transactions between October 14 and October 15, 2026. During this period, he exercised options to acquire 152,905 shares and sold 78,369 shares on the market.
Key points
- In mid-October 2026, Moderna President Stephen Hoge conducted several company stock transactions.
- All cited transactions were conducted under a 10b5-1 plan, a preset selling schedule executives set up to avoid suspicions of insider trading.
Company president's transactions
In mid-October 2026, Moderna President Stephen Hoge conducted several company stock transactions. Over two days, he acquired 152,905 shares through option exercises and sold 78,369 shares on the open market. The total value of the shares sold was $17,013,537.68.
Why this should not be considered a signal
All cited transactions were conducted under a 10b5-1 plan, a preset selling schedule executives set up to avoid suspicions of insider trading. This plan was adopted on June 15, 2026. Therefore, such sales are automatic and planned in advance, rather than indicating a change in the executive's outlook on business prospects.
Original sources
Cite this article
The fingerprint identifies the exact version of each original that the article was written from; the original stays at its source.
Follow Moderna
A notification in your browser or on your phone when we publish about Moderna. Free, no email, no account, no app.
Prepared by AI from official company documents; automatic checks and an AI editor review it before publication, and not every article is read by a person. This is not investment advice. Editorial standards
